このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Becton Dickinson 将来の成長
Future 基準チェック /26
Becton Dickinson利益と収益がそれぞれ年間16.3%と5.1%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に15.5% 15.7%なると予測されています。
主要情報
15.9%
収益成長率
15.1%
EPS成長率
| Medical Equipment 収益成長 | 17.5% |
| 収益成長率 | 5.3% |
| 将来の株主資本利益率 | 15.5% |
| アナリストカバレッジ | Good |
| 最終更新日 | 25 Sep 2024 |
今後の成長に関する最新情報
Recent updates
Becton, Dickinson and Company: Future Benefit From GLP-1 Drug Delivery
Sep 13Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy
Aug 06Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price
Jul 16
An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued
Jun 27Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?
May 24Becton, Dickinson and Company: Stagnating All Along
May 16Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)
Mar 23Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)
Feb 29Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings
Feb 08Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 03These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Feb 01Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play
Jan 22Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 30Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24
Nov 13Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's
Nov 12Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price
Nov 06With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case
Oct 05Becton, Dickinson Stock Is A Hold, Here's Why
Oct 04Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers
Aug 30We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Aug 13Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Jul 28Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching
Jun 22Becton, Dickinson and Company: Still Not Very Healthy
Jun 20Becton, Dickinson: Business Should Beat H2 2023 Expectations
Jun 08These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Apr 22Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?
Mar 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Mar 05Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use
Feb 21Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test
Feb 08Becton, Dickinson Q1 2023 Earnings Preview
Feb 01Becton, Dickinson declares $0.91 dividend
Jan 24We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Jan 09CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod
Jan 09業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 9/30/2026 | 22,481 | 2,647 | 3,465 | 4,888 | 11 |
| 9/30/2025 | 21,532 | 2,423 | 4,206 | 4,895 | 16 |
| 9/30/2024 | 20,152 | 2,002 | 3,028 | 4,486 | 16 |
| 6/30/2024 | 19,828 | 1,459 | 3,221 | 3,944 | N/A |
| 3/31/2024 | 19,716 | 1,364 | 3,025 | 3,760 | N/A |
| 12/31/2023 | 19,492 | 1,265 | 2,649 | 3,431 | N/A |
| 9/30/2023 | 19,372 | 1,470 | 2,115 | 2,989 | N/A |
| 6/30/2023 | 19,046 | 1,582 | 1,743 | 2,638 | N/A |
| 3/31/2023 | 18,809 | 1,556 | 1,009 | 1,966 | N/A |
| 12/31/2022 | 18,738 | 1,486 | 1,361 | 2,359 | N/A |
| 9/30/2022 | 18,870 | 1,545 | 1,661 | 2,634 | N/A |
| 6/30/2022 | 18,958 | 1,412 | 1,465 | 2,575 | N/A |
| 3/31/2022 | 18,924 | 1,430 | 2,041 | 3,141 | N/A |
| 12/31/2021 | 18,534 | 1,079 | 2,620 | 3,751 | N/A |
| 9/30/2021 | 19,131 | 1,514 | 3,453 | 4,647 | N/A |
| 6/30/2021 | 19,066 | 1,486 | 4,222 | 5,177 | N/A |
| 3/31/2021 | 18,313 | 1,379 | 4,150 | 5,064 | N/A |
| 12/31/2020 | 18,207 | 1,507 | 3,476 | 4,359 | N/A |
| 9/30/2020 | 16,074 | 245 | 2,728 | 3,497 | N/A |
| 6/30/2020 | 16,917 | 786 | 2,474 | 3,429 | N/A |
| 3/31/2020 | 17,414 | 923 | 2,509 | 3,499 | N/A |
| 12/31/2019 | 17,355 | 760 | 2,835 | 3,798 | N/A |
| 9/30/2019 | 17,290 | 1,081 | 2,373 | 3,330 | N/A |
| 6/30/2019 | 17,108 | 784 | 2,359 | 3,265 | N/A |
| 3/31/2019 | 17,036 | 926 | 2,009 | 2,875 | N/A |
| 12/31/2018 | 17,063 | 894 | 1,906 | 2,790 | N/A |
| 9/30/2018 | 15,983 | 159 | 1,970 | 2,865 | N/A |
| 6/30/2018 | 14,747 | 621 | 1,837 | 2,685 | N/A |
| 3/31/2018 | 13,503 | -99 | N/A | 2,527 | N/A |
| 12/31/2017 | 12,251 | 294 | N/A | 2,555 | N/A |
| 9/30/2017 | 12,093 | 1,030 | N/A | 2,550 | N/A |
| 6/30/2017 | 12,158 | 759 | N/A | 2,129 | N/A |
| 3/31/2017 | 12,321 | 1,314 | N/A | 2,579 | N/A |
| 12/31/2016 | 12,419 | 1,309 | N/A | 2,411 | N/A |
| 9/30/2016 | 12,483 | 976 | N/A | 2,559 | N/A |
| 6/30/2016 | 12,312 | 1,139 | N/A | 2,532 | N/A |
| 3/31/2016 | 12,234 | 810 | N/A | 2,236 | N/A |
| 12/31/2015 | 11,217 | 688 | N/A | 1,907 | N/A |
| 9/30/2015 | 10,282 | 695 | N/A | 1,730 | N/A |
| 6/30/2015 | 9,410 | 815 | N/A | 1,591 | N/A |
| 3/31/2015 | 8,448 | 1,079 | N/A | 1,492 | N/A |
| 12/31/2014 | 8,468 | 1,150 | N/A | 1,677 | N/A |
| 9/30/2014 | 8,446 | 1,185 | N/A | 1,746 | N/A |
| 6/30/2014 | 8,345 | 974 | N/A | 1,876 | N/A |
| 3/31/2014 | 8,239 | 941 | N/A | 1,830 | N/A |
| 12/31/2013 | 8,169 | 930 | N/A | 1,626 | N/A |
| 9/30/2013 | 8,054 | 929 | N/A | 1,505 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: BDXの予測収益成長率 (年間18% ) は 貯蓄率 ( 2.4% ) を上回っています。
収益対市場: BDXの収益 ( 18% ) はUS市場 ( 14.8% ) よりも速いペースで成長すると予測されています。
高成長収益: BDXの収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: BDXの収益 ( 5.1% ) US市場 ( 8.8% ) よりも低い成長が予測されています。
高い収益成長: BDXの収益 ( 5.1% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: BDXの 自己資本利益率 は、3年後には低くなると予測されています ( 15.5 %)。